Mylan Inks $30M SEC Deal After Not Disclosing EpiPen Probe
By Rachel Graf · September 27, 2019, 11:16 AM EDT
Mylan NV will pay the U.S. Securities and Exchange Commission $30 million to resolve allegations that it failed to warn investors about potential losses tied to an investigation into the drugmaker's...
To view the full article, register now.